Monitoring is crucial for the safe and effective use of anticoagulant therapy. Traditional anticoagulants like warfarin require regular INR (International Normalized Ratio) monitoring to ensure therapeutic levels are maintained without significant bleeding risk. Newer DOACs have more predictable pharmacokinetics and generally require less frequent monitoring.
